| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/07/2005 | US20050148013 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/07/2005 | US20050148008 Compositions and methods relating to ovarian specific genes and proteins |
| 07/07/2005 | US20050147999 Lyme disease vaccines |
| 07/07/2005 | US20050147995 identification, on human chromosome 10, of a tumor suppressor gene. Defects in this gene are associated with the development of cancers, such as gliomas |
| 07/07/2005 | US20050147993 Recombinant high mobility polypeptide comprisingprotein transduction domain linked to non-nuclear organelle targeting signal; gene transfer vector |
| 07/07/2005 | US20050147971 Biomolecule transduction motif mph-1-btm and the use thereof |
| 07/07/2005 | US20050147970 Using concentration of histone acetyltransferase in mammary gland tissues as diagnostic/prognostic indicator of cell proliferative disorders |
| 07/07/2005 | US20050147960 Propagating multipotent cells on biological scaffold in presence of cell growth factor and determining and/or screening for controlled development, self-assembly or differentiation; regenerative medicine; tissue engineering |
| 07/07/2005 | US20050147689 Method for inhibiting the growth of gastrointestinal tract tumors |
| 07/07/2005 | US20050147687 Inducing a phase change, e.g. heating at a controlled rate, in a solution of alpha-1-antitrypsin (AAT), a phase separation promoter and a solvent to form particles and a liquid phase of the promoter and solvent; nano- and microspheres of 0.01-200 mu m; drug delivery; embryonic encapsulated particles |
| 07/07/2005 | US20050147684 A hematopoietic growth factor, a liquid vehicle, a first and second biocompatible polymers; exhibits reverse-thermal viscosity behavior due to interaction between the first polymer and vehicle; the second polymer forms a protective colloid; sustained delivery; increased half-life; side effect reduction |
| 07/07/2005 | US20050147683 A hematopoietic growth factor, a liquid vehicle, a first and second biocompatible polymers; exhibits reverse-thermal viscosity behavior due to interaction between the first polymer and vehicle; the second polymer forms a protective colloid; sustained delivery; increased half-life; side effect reduction |
| 07/07/2005 | US20050147682 A hematopoietic growth factor, a liquid vehicle, a first and second biocompatible polymers; exhibits reverse-thermal viscosity behavior due to interaction between the first polymer and vehicle; the second polymer forms a protective colloid; sustained delivery; increased half-life; side effect reduction |
| 07/07/2005 | US20050147679 An aqueous eye drop solution of hydrolyzed collagen to promote and protect tissue and cell growth, reduce scar tissue and repair connective tissues; wound healing agents; bandages; carriers preferably combined with hyaluronic acid or a salt, a polysulfated glycosaminoglycan and/or a glucosamine salt |
| 07/07/2005 | US20050147662 Compounds and compositions for delivering active agents |
| 07/07/2005 | US20050147659 Oil/water/oil double microemulsion incorporated into solid support constituted by microporous inorganic substance or by an adsorbent colloidal inorganic substance or cross-linked swellable in water polymer, wherein drug is dissolved or dispersed in one or more phases of microemulsion; improved solubility |
| 07/07/2005 | US20050147649 Method and dietary composition for improving fat digestibility |
| 07/07/2005 | US20050147643 Treating varicose or veins by injecting a composition silk made of polyalkylene oxide-polyester block copolymer into the lumen of a vein; anchoring implantable medical devices into or onto biological tissue |
| 07/07/2005 | US20050147628 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 07/07/2005 | US20050147626 administering clostridium to nerves for treatment of epilepsy and pain |
| 07/07/2005 | US20050147625 administering clostridial toxins for treatment of motion sickness |
| 07/07/2005 | US20050147615 Compositions and methods for the therapy and diagnosis of colon cancer |
| 07/07/2005 | US20050147613 using bispecific antibodies comprising an antibody having binding specificity which confers the ability to cross the blood-brain barrier, and a second antibody conferring the ability to bind to beta -amyloid epitopes, used for the treatment of Alzheimer's disease or Down's syndrome |
| 07/07/2005 | US20050147612 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 07/07/2005 | US20050147611 Combination therapy for conditions leading to bone loss |
| 07/07/2005 | US20050147609 and arthritis comprising administering of interleukin-17 and/or leukocyte inhibitory factor (LIF) antagonists, antibodies |
| 07/07/2005 | US20050147601 Angiogenesis inhibitor; wound healing agents; prevent cell adhesion in mallals |
| 07/07/2005 | US20050147600 Angiotensin converting enzyme homolog and uses therefor |
| 07/07/2005 | US20050147599 Medical implants and fibrosis-inducing agents |
| 07/07/2005 | US20050147597 Isolating autologous mononuclear cells and transplanting locally into injured tissue |
| 07/07/2005 | US20050147592 Correcting underlying genetic defect; delivering heterologous gene encoding metabolic protein causing transduction of cells resulting in expression from transformed cell genetics |
| 07/07/2005 | US20050147588 Reducing body fat utilizing interferon tau |
| 07/07/2005 | US20050147587 Protein fusion comprising colony stimulating factor activity for use as tool in rapid stimulation and production of white blood cells and neutrophils |
| 07/07/2005 | US20050147586 Novel therapeutic processes and useful compositions therefor |
| 07/07/2005 | US20050147581 Molar ratio of acidic polymer to protein therapeutic in excess of stoichiometric requirement; such as pulmonary delivery of somatropin |
| 07/07/2005 | US20050147574 Inhibitors of proteasomal activity for stimulating hair growth |
| 07/07/2005 | US20050147568 nanostructured acid addition salt of 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, used for the treatment of headaches |
| 07/07/2005 | US20050147567 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 07/07/2005 | US20050147562 for treating or preventing gastroesophageal reflux disease (GERD) |
| 07/07/2005 | DE10358525A1 Endoparasitizide Mittel zur topischen Applikation Endoparasiticidal compositions for topical application |
| 07/07/2005 | DE10357970A1 Lösungsmittel für biogene pharmazeutische Wirkstoffe Solvent for biogenic active pharmaceutical ingredients |
| 07/07/2005 | DE10356409A1 Neues Arzneimittel Oxachelin und Derivate New drug Oxachelin and derivatives |
| 07/07/2005 | DE10356076A1 Pharmaceutical preparation, for the treatment of obesity and type II diabetes, uses associated proteins to inhibit or encourage the deposit of lipid molecules in adipocytes |
| 07/07/2005 | DE10105038B4 Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 07/07/2005 | CA2800228A1 Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 07/07/2005 | CA2551504A1 Use of il-6 in the preparation of pharmaceutical compositions for treating and preventing liver injury |
| 07/07/2005 | CA2551190A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins. |
| 07/07/2005 | CA2551189A1 Therapeutic agents and uses therefor |
| 07/07/2005 | CA2551183A1 Process for producing pellets for pharmaceutical compositions |
| 07/07/2005 | CA2551009A1 A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 07/07/2005 | CA2550632A1 Isopeptide gap junction modulators |
| 07/07/2005 | CA2550217A1 Glp-1 (9-36) methods and compositions |
| 07/07/2005 | CA2550215A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 07/07/2005 | CA2549863A1 Use of relaxin as adjuvant in the differentiation of stem cells for the reconstruction of tissues |
| 07/07/2005 | CA2549796A1 Secreted neural apoptosis inhibiting proteins |
| 07/07/2005 | CA2549306A1 Methods of modulating cytokine activity; related reagents |
| 07/07/2005 | CA2549249A1 Muteins of fibroblast growth factor 21 |
| 07/07/2005 | CA2548740A1 Treatment of viral infections |
| 07/07/2005 | CA2548462A1 Medicament comprising ptx3, alone or in combination with tsg-6, for treating degenerative diseases of cartilage and bone and treating female infertility |
| 07/07/2005 | CA2548452A1 Medicament comprising inhibitors of long pentraxin ptx3 |
| 07/07/2005 | CA2547338A1 Composition and methods for modulating cns activity |
| 07/07/2005 | CA2545777A1 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 07/07/2005 | CA2545632A1 A pharmaceutical composition comprising an active principle and a non-detergent sulphobetaine |
| 07/07/2005 | CA2543578A1 Genes commonly regulated by different classes of antidepressants |
| 07/07/2005 | CA2523998A1 Novel antimicrobial peptides |
| 07/07/2005 | CA2522421A1 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein |
| 07/06/2005 | EP1550729A1 Target binding polypeptide comprising an IG-like VL domain linked to an IG-like VH domain |
| 07/06/2005 | EP1550719A1 Methods and medicament for inhibition the expression of a defined gene |
| 07/06/2005 | EP1550715A1 Method for the regeneration of tissue |
| 07/06/2005 | EP1550672A1 Chimeric antagonist anth1 |
| 07/06/2005 | EP1550671A1 Placenta derived apoptotic factor |
| 07/06/2005 | EP1550456A2 Use of botulinum toxin in the treatment of burn pain |
| 07/06/2005 | EP1550455A1 Agent neutralizint tissue factor inhibitor and agent neutralizing activated blood coagulation factor viii preparation |
| 07/06/2005 | EP1550454A1 Extracorporeal photopheresis in combination with anti-TNF treatment |
| 07/06/2005 | EP1550449A1 Antitumor agents with the use of hsv |
| 07/06/2005 | EP1550439A1 Method for preparing a solid dosage form of desmopressin |
| 07/06/2005 | EP1549957A2 Method for determining the susceptibility of a subject to infection |
| 07/06/2005 | EP1549956A2 Screening method |
| 07/06/2005 | EP1549951A2 Semaphorin-like proteins and methods of using same |
| 07/06/2005 | EP1549950A1 Methods for identifying glucose uptake modulators |
| 07/06/2005 | EP1549771A2 Method for diagnosing pancreatic cancer |
| 07/06/2005 | EP1549767A2 Modulation of forkhead box o1a expression |
| 07/06/2005 | EP1549760A2 Sak: modulation of cellular proliferation for treatment of cancer |
| 07/06/2005 | EP1549749A2 Compositions, organisms and methodologies employing a novel human kinase |
| 07/06/2005 | EP1549748A1 Single chain recombinant t cell receptors |
| 07/06/2005 | EP1549747A2 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 07/06/2005 | EP1549746A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 07/06/2005 | EP1549740A2 Oligodendrocyte production from multipotent neural stem cells |
| 07/06/2005 | EP1549679A1 Fusion protein comprising angiopoietin receptor-binding and a multimerization domain |
| 07/06/2005 | EP1549677A2 FVII OR FVIIa VARIANTS HAVING INCREASED CLOTTING ACTIVITY |
| 07/06/2005 | EP1549676A1 Genes and polypeptides relating to human myeloid leukemia |
| 07/06/2005 | EP1549673A2 Novel mhc ii associated peptides |
| 07/06/2005 | EP1549672A2 Ablated slam-dependent entry |
| 07/06/2005 | EP1549671A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/06/2005 | EP1549670A1 Template-fixed peptidomimetics with antimicrobial activity |
| 07/06/2005 | EP1549669A1 Tumor targeting agents and uses thereof |
| 07/06/2005 | EP1549668A1 Tumor targeting agents and uses thereof |
| 07/06/2005 | EP1549667A1 Tumor targeting agents and uses thereof |
| 07/06/2005 | EP1549663A2 Multifunctional polypeptides |
| 07/06/2005 | EP1549660A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |